GNH USA

USA — NDC

Smofkabiven 0.21 g

SMOFKABIVEN 0.21 G is an intravenous emulsion containing sodium glycerophosphate, designed for nutritional support. This product is manufactured by Fresenius Ka

Sodium Glycerophosphate
SMOFKABIVEN
EMULSION
0.21 G

Request sourcing

1
Pack/s

What is Sodium Glycerophosphate?

SMOFKABIVEN 0.21 G is an intravenous emulsion containing sodium glycerophosphate, designed for nutritional support. This product is manufactured by Fresenius Kabi Canada Ltd. and is suitable for medical use.

What is Sodium Glycerophosphate used for?

SMOFKABIVEN 0.21 G is primarily used for intravenous nutrition, providing essential nutrients to patients who cannot consume food orally. It is often used in clinical settings to support patients who require nutritional supplementation due to various medical conditions. This emulsion helps in maintaining adequate nutrient levels in the body.

What are the side effects of Sodium Glycerophosphate?

When administered intravenously, SMOFKABIVEN 0.21 G provides essential nutrients directly into the bloodstream. This can help in maintaining energy levels and supporting overall health. Patients may experience improved nutritional status and better overall well-being when used as directed by a healthcare professional.

What precautions apply to Sodium Glycerophosphate?

SMOFKABIVEN 0.21 G should be administered under the supervision of a healthcare professional. It is important to follow proper handling and storage guidelines to ensure the product remains effective. Patients should be monitored for any adverse reactions during and after administration.

What does Sodium Glycerophosphate interact with?

SMOFKABIVEN 0.21 G may interact with other medications or supplements. It is important to inform your healthcare provider about all medications you are taking before starting this treatment. Always follow the advice of a healthcare professional regarding potential interactions.

Frequently asked questions

What is SMOFKABIVEN 0.21 G used for?+
SMOFKABIVEN 0.21 G is used for intravenous nutrition, providing essential nutrients to patients who cannot consume food orally.
How is SMOFKABIVEN 0.21 G administered?+
SMOFKABIVEN 0.21 G is administered intravenously, directly into the bloodstream, under the supervision of a healthcare professional.
What are the common effects of SMOFKABIVEN 0.21 G?+
Common effects include improved nutritional status and better overall well-being, as it provides essential nutrients directly into the bloodstream.
Are there any precautions to consider when using SMOFKABIVEN 0.21 G?+
Yes, it should be administered under the supervision of a healthcare professional, and proper handling and storage guidelines should be followed.
Can SMOFKABIVEN 0.21 G interact with other medications?+
Yes, it may interact with other medications or supplements, so it is important to inform your healthcare provider about all medications you are taking.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Sodium Glycerophosphate
Brand
SMOFKABIVEN
Strength
0.21 G
Form
EMULSION
Route
INTRAVENOUS
Pack size
986/1477/1970/2463ML
Manufacturer
FRESENIUS KABI CANADA LTD
Origin
CANADA

Related products